West Pharmaceutical Services, Inc. has expanded capabilities at its Scottsdale, Arizona facility for its SmartDose Electronic Wearable Injector. The expansion in Scottsdale will enable continuing development and production of SmartDose to accommodate increased demand for the product.

SmartDose is a single-use, electronic wearable injector that adheres to the patient's body, usually on the abdomen, and is pre-programmed to deliver high volumes of viscous or sensitive drug products. SmartDose includes a Daikyo Crystal Zenith drug container with elastomer components using FluroTec barrier film. The needle is automatically shielded before and after use to help prevent the risk of accidental needlestick injury. Designed to deliver high volumes of injectable drugs over an extended period of time, SmartDosea allows patients to self-administer medication. West has delivered more than 100,000 units of SmartDose and more than 800,000 validated Daikyo Crystal Zenith drug containers to pharmaceutical manufacturers for customer-funded development projects and clinical trials, including eight active programs at various stages of precommercial development.

The expanded capabilities at the Scottsdale site include cleanroom manufacturing and additional laboratory space. New jobs are being created in R&D, engineering, quality, and operations functions to ramp up production, new development, and engineering.

Source: West Pharmaeutical Services